Expert Stories

After MIT training and embedding AI into my vaccine research at EdJen Biotech, DigitalKin’s literature-review Kin was a revelation — rigorous, publication-grade intelligence, not generic output. So I went further: I’m now building Kin SAB with DigitalKin, the world’s first AI-powered Scientific Advisory Board assistant —delivering hallucination-free intelligence when it matters most. Top-tier science, within reach of every biotech, life sciences investor, and R&D team on the planet.

For several years, we've been exploring how AI can enrich our expertise. With SpoK PME, we're taking the next step : making brand strategy accessible to SMEs and startups. We chose DigitalKin because their platform is the only one that lets us encode our real methodology into a high-level AI service, not just wrap a chatbot in our brand. Our ambition is simple: help more companies understand what makes them unique and turn that singularity into a competitive edge.

I've spent years at the crossroads of research and business, and I know what a rigorous literature review demands. When I saw what DigitalKin's technology could do - not generate generic summaries, but actually search, filter and structure with real methodological discipline - I knew this was worth putting my name behind. This service delivers the scientific standard I would expect from any R&D Teams.

I spent years helping companies design their business models. When we built DigitalKin, I realized the experts we onboard face the same question I used to answer as a consultant: where's my best opportunity? So I built a Kin that does it. It analyzes each expert's know-how and identifies the autonomous business with the highest potential. I used to do this in workshops. Now the Kin does it. Faster, sharper, and at scale.